Drugs / Inactivated Influenza Vaccine (Split Virion)
Inactivated Influenza Vaccine (Split Virion)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00343681 | Jul 2006 → Aug 2007 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01554813 Comparator | May → Jul 2006 | influenza | Hualan Biological Engineering, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated influenza vaccine (split virion) | “A Single - Blind, Randomized, - Controlled Clinical Trial With Inactivated Influenza Vaccine (Split Virion) (0.5ml Formulation)” NCT01554813 ↗ |
| Modality | Vaccine | “Inactivated, Split-Virion Influenza Vaccine” NCT00343681 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00343681 ↗ |